Literature DB >> 26563284

Cutaneous immunology: basics and new concepts.

Amir S Yazdi1, Martin Röcken1, Kamran Ghoreschi2.   

Abstract

As one of the largest organs, the skin forms a mechanical and immunological barrier to the environment. The skin immune system harbors cells of the innate immune system and cells of the adaptive immune system. Signals of the innate immune system typically initiate skin immune responses, while cells and cytokines of the adaptive immune system perpetuate the inflammation. Skin immune responses ensure effective host defense against pathogens but can also cause inflammatory skin diseases. An extensive crosstalk between the different cell types of the immune system, tissue cells, and pathogens is responsible for the complexity of skin immune reactions. Here we summarize the major cellular and molecular components of the innate and adaptive skin immune system.

Entities:  

Mesh:

Year:  2015        PMID: 26563284     DOI: 10.1007/s00281-015-0545-x

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   11.759


  72 in total

1.  Reversal of established delayed type hypersensitivity reactions following therapy with IL-4 or antigen-specific Th2 cells.

Authors:  T Biedermann; R Mailhammer; A Mai; C Sander; A Ogilvie; F Brombacher; K Maier; A D Levine; M Röcken
Journal:  Eur J Immunol       Date:  2001-05       Impact factor: 5.532

2.  Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5.

Authors:  Xiang-Ping Yang; Kamran Ghoreschi; Scott M Steward-Tharp; Jaime Rodriguez-Canales; Jinfang Zhu; John R Grainger; Kiyoshi Hirahara; Hong-Wei Sun; Lai Wei; Golnaz Vahedi; Yuka Kanno; John J O'Shea; Arian Laurence
Journal:  Nat Immunol       Date:  2011-01-30       Impact factor: 25.606

Review 3.  Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis.

Authors:  Jasvinder A Singh; Chris Cameron; Shahrzad Noorbaloochi; Tyler Cullis; Matthew Tucker; Robin Christensen; Elizabeth Tanjong Ghogomu; Doug Coyle; Tammy Clifford; Peter Tugwell; George A Wells
Journal:  Lancet       Date:  2015-05-11       Impact factor: 79.321

4.  Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry.

Authors:  D Salmon-Ceron; F Tubach; O Lortholary; O Chosidow; S Bretagne; N Nicolas; E Cuillerier; B Fautrel; C Michelet; J Morel; X Puéchal; D Wendling; M Lemann; P Ravaud; X Mariette
Journal:  Ann Rheum Dis       Date:  2010-12-21       Impact factor: 19.103

5.  NLRC5 deficiency selectively impairs MHC class I- dependent lymphocyte killing by cytotoxic T cells.

Authors:  Francesco Staehli; Kristina Ludigs; Leonhard X Heinz; Queralt Seguín-Estévez; Isabel Ferrero; Marion Braun; Kate Schroder; Manuele Rebsamen; Aubry Tardivel; Chantal Mattmann; H Robson MacDonald; Pedro Romero; Walter Reith; Greta Guarda; Jürg Tschopp
Journal:  J Immunol       Date:  2012-03-12       Impact factor: 5.422

Review 6.  Signal transduction pathways and transcriptional regulation in Th17 cell differentiation.

Authors:  Kiyoshi Hirahara; Kamran Ghoreschi; Arian Laurence; Xiang-Ping Yang; Yuka Kanno; John J O'Shea
Journal:  Cytokine Growth Factor Rev       Date:  2010-11-16       Impact factor: 7.638

7.  Effects of systemic interleukin-10 therapy on psoriatic skin lesions: histologic, immunohistologic, and molecular biology findings.

Authors:  K Asadullah; M Friedrich; S Hanneken; C Rohrbach; H Audring; A Vergopoulos; M Ebeling; W D Döcke; H D Volk; W Sterry
Journal:  J Invest Dermatol       Date:  2001-05       Impact factor: 8.551

8.  IL-4 abrogates T(H)17 cell-mediated inflammation by selective silencing of IL-23 in antigen-presenting cells.

Authors:  Emmanuella Guenova; Yuliya Skabytska; Wolfram Hoetzenecker; Günther Weindl; Karin Sauer; Manuela Tham; Kyu-Won Kim; Ji-Hyeon Park; Ji Hae Seo; Desislava Ignatova; Antonio Cozzio; Mitchell P Levesque; Thomas Volz; Martin Köberle; Susanne Kaesler; Peter Thomas; Reinhard Mailhammer; Kamran Ghoreschi; Knut Schäkel; Boyko Amarov; Martin Eichner; Martin Schaller; Rachael A Clark; Martin Röcken; Tilo Biedermann
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

9.  Long-term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate-to-severe psoriasis: results from the PHOENIX 2 study through 5 years of follow-up.

Authors:  R G Langley; M Lebwohl; G G Krueger; P O Szapary; Y Wasfi; D Chan; M C Hsu; Y You; Y Poulin; N Korman; J C Prinz; K Reich
Journal:  Br J Dermatol       Date:  2015-03-22       Impact factor: 9.302

10.  The inflammasome mediates UVB-induced activation and secretion of interleukin-1beta by keratinocytes.

Authors:  Laurence Feldmeyer; Martin Keller; Gisela Niklaus; Daniel Hohl; Sabine Werner; Hans-Dietmar Beer
Journal:  Curr Biol       Date:  2007-07-03       Impact factor: 10.834

View more
  14 in total

1.  Instantaneous depolarization of T cells via dopamine receptors, and inhibition of activated T cells of Psoriasis patients and inflamed human skin, by D1-like receptor agonist: Fenoldopam.

Authors:  Aviad Keren; Amos Gilhar; Yehuda Ullmann; Marina Zlotkin-Frušić; Yoram Soroka; Abraham J Domb; Mia Levite
Journal:  Immunology       Date:  2019-11       Impact factor: 7.397

2.  Pathogenicity of acquired immunity in human diseases.

Authors:  Kiyoshi Hirahara
Journal:  Semin Immunopathol       Date:  2019-05-07       Impact factor: 9.623

Review 3.  Skin immunity and its dysregulation in atopic dermatitis, hidradenitis suppurativa and vitiligo.

Authors:  Elena Campione; Caterina Lanna; Laura Diluvio; Maria Vittoria Cannizzaro; Sandro Grelli; Marco Galluzzo; Marina Talamonti; Margherita Annicchiarico-Petruzzelli; Mara Mancini; Gerry Melino; Eleonora Candi; Gianfranco Schiavone; Ying Wang; Yufang Shi; Luca Bianchi
Journal:  Cell Cycle       Date:  2020-01-05       Impact factor: 4.534

Review 4.  Recent advances in understanding psoriasis.

Authors:  Franziska C Eberle; Jürgen Brück; Julia Holstein; Kiyoshi Hirahara; Kamran Ghoreschi
Journal:  F1000Res       Date:  2016-04-28

Review 5.  TWEAK/Fn14 Activation Participates in Skin Inflammation.

Authors:  Qilu Liu; Shengxiang Xiao; Yumin Xia
Journal:  Mediators Inflamm       Date:  2017-09-06       Impact factor: 4.711

6.  East Indian Sandalwood Oil (EISO) Alleviates Inflammatory and Proliferative Pathologies of Psoriasis.

Authors:  Manju Sharma; Corey Levenson; Ian Clements; Paul Castella; Kurt Gebauer; Michael E Cox
Journal:  Front Pharmacol       Date:  2017-03-16       Impact factor: 5.810

Review 7.  Ticks and Tick-Borne Infections: Complex Ecology, Agents, and Host Interactions.

Authors:  Stephen K Wikel
Journal:  Vet Sci       Date:  2018-06-20

Review 8.  Nrf2 Involvement in Chemical-Induced Skin Innate Immunity.

Authors:  Doumet Georges Helou; Stefan F Martin; Marc Pallardy; Sylvie Chollet-Martin; Saadia Kerdine-Römer
Journal:  Front Immunol       Date:  2019-05-07       Impact factor: 7.561

Review 9.  The Brain-Skin Connection and the Pathogenesis of Psoriasis: A Review with a Focus on the Serotonergic System.

Authors:  Ana M Martins; Andreia Ascenso; Helena M Ribeiro; Joana Marto
Journal:  Cells       Date:  2020-03-26       Impact factor: 6.600

10.  Lower-Sized Chitosan Nanocapsules for Transcutaneous Antigen Delivery.

Authors:  Juan I Bussio; Carla Molina-Perea; José Vicente González-Aramundiz
Journal:  Nanomaterials (Basel)       Date:  2018-08-26       Impact factor: 5.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.